PTN and prostate cancer: The two analytes PTN and TNFRSF9 remained the most predictive features besides the NCCN risk score, and the three features combined predicted prostate cancer-specific mortality with 90% accuracy (Supplementary Fig. 7B, Supplementary Fig. 8).